New Mexico Cancer Center offering advanced breast cancer fighting technology ...

Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s ...

Recent approvals of trastuzumab deruxtecan (T-DXd; Enhertu) in early HER2-positive breast cancer have created new questions about its optimal use in the neoadjuvant and adjuvant settings. Rugo: Let's ...

I was constantly analyzing lab results and triaging myself at home. Here’s how I finally found peace.

The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.

Jessie J split from Chanan Colman "some time ago".The 38-year-old singer had been dating the basketball player since 2021 but ...

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

US FDA approves Keytruda and Keytruda Qlex, each with Trodelvy as first-line treatment of PD-L1+ (CPS =10) advanced TNBC: Rahway, New Jersey Friday, June 26, 2026, 09:00 Hrs [IST] ...

Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).

Key Points Interested in OnKure Therapeutics, Inc.? Here are five stocks we like better. OnKure Therapeutics is advancing two ...